The Year of Concentration, Crypto, China

In this podcast, Motley Fool host Dylan Lewis and analysts Bill Mann and Matt Argersinger discuss: Why 2024 was such a good year for investors, and the concerns they have about valuations and market concentration as they look ahead to 2025. The…Read More »

Better Income Stock: Pfizer or Altria Group?

High-yielding dividend stocks often attract the attention of investors—and for good reason. When established companies maintain larger than average dividend payments, they can provide substantial current income and the potential for long-term appreciation. However, unusually high yields can be a double-edged sword.…Read More »